As seen in Figure 5(b), 3 μM pimozide pretreatment dramatically suppressed IL-2-induced STAT5 phosphorylation, indicating that it is a potent blocker of IL-2-stimulated STAT5 phosphorylation in PBMCs from CKD patients. The gene discussed is IL2; the disease is chronic kidney disease.